ACYCLOVIR- acyclovir capsule Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir- acyclovir capsule

pd-rx pharmaceuticals, inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 200 mg - acyclovir is indicated for the acute treatment of herpes zoster (shingles). acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. acyclovir is indicated for the treatment of chickenpox (varicella). acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR ointment Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir ointment

northstar rx llc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

ACYCLOVIR ointment Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir ointment

amneal pharmaceuticals llc - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

ACYCLOVIR- acyclovir sodium injection, solution Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir- acyclovir sodium injection, solution

fresenius kabi usa, llc - acyclovir sodium (unii: 927l42j563) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 ml - acyclovir sodium injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (hsv-1 and hsv-2) in immunocompromised patients. acyclovir sodium injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immuno-competent patients. acyclovir sodium injection is indicated for the treatment of herpes simplex encephalitis. acyclovir sodium injection is indicated for the treatment of neonates and infants with herpes simplex infections. acyclovir sodium injection is indicated for the treatment of varicella-zoster (shingles) infections in immunocompromised patients. acyclovir sodium injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR- acyclovir sodium injection, solution Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir- acyclovir sodium injection, solution

fresenius kabi usa, llc - acyclovir sodium (unii: 927l42j563) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 ml - acyclovir sodium injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (hsv-1 and hsv-2) in immunocompromised patients. acyclovir sodium injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immuno-competent patients. acyclovir sodium injection is indicated for the treatment of herpes simplex encephalitis. acyclovir sodium injection is indicated for the treatment of neonates and infants with herpes simplex infections. acyclovir sodium injection is indicated for the treatment of varicella-zoster (shingles) infections in immunocompromised patients. acyclovir sodium injection is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

cyclophosphamide- Cyclophosphamide tablet Estados Unidos - inglés - NLM (National Library of Medicine)

cyclophosphamide- cyclophosphamide tablet

roxane laboratories, inc. - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide - unii:8n3dw7272p) - tablet - 25 mg - cyclophosphamide tablets, although effective alone in susceptible malignancies, are more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible to cyclophosphamide treatment: - malignant lymphomas (stages iii and iv of the ann arbor staging system), hodgkin’s disease, lyphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, burkitt’s lymphoma. - multiple myeloma. - leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia; acute lymphoblastic (stem-cell) leukemia in children (cyclophosphamide given during remission is effective in prolonging its duration). - mycosis fungoides (advanced disease). - neuroblastoma (disseminated disease). - adenocarcinoma of the ovary. - retinoblastoma. - carcinoma of the breast. cyclophosphamide tablets are useful in carefully selected cases of biopsy proven “minimal c

CYCLOBENZAPRINE HYDROCHLORIDE- cyclobenzaprine hydrochloride tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

cyclobenzaprine hydrochloride- cyclobenzaprine hydrochloride tablet, film coated

clinical solutions wholesale - cyclobenzaprine hydrochloride (unii: 0ve05jys2p) (cyclobenzaprine - unii:69o5wqq5ti) - cyclobenzaprine hydrochloride 10 mg - cyclobenzaprine hydrochloride is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. cyclobenzaprine hydrochloride should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. cyclobenzaprine hydrochloride has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. hypersensitivity to any component of this product. concomitant use of monoamine oxidase (mao) inhibitors or within 14 days after their dis

ACYCLOVIR- acyclovir suspension Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir- acyclovir suspension

atlantic biologicals corps - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 200 mg in 5 ml - acyclovir oral suspension, usp is indicated for the acute treatment of herpes zoster (shingles). acyclovir oral suspension, usp is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. acyclovir oral suspension, usp is indicated for the treatment of chickenpox (varicella). acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR tablet Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir tablet

rebel distributors corp - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 400.00 mg - herpes zoster infections: acyclovir capsules, usp and acyclovir tablets, usp are indicated for the acute treatment of herpes zoster (shingles). genital herpes: acyclovir capsules, usp and acyclovir tablets, usp are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. chickenpox: acyclovir capsules, usp and acyclovir tablets, usp are indicated for the treatment of chickenpox (varicella). acyclovir is contraindicated for patients who develop hypersensitivity to acyclovir or valacyclovir.

ACYCLOVIR ointment Estados Unidos - inglés - NLM (National Library of Medicine)

acyclovir ointment

tolmar inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment, 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.